Complete tumour clearance in gastric cancer animal study

Summary by 6ix AI

Arovella Therapeutics Limited reports positive results from an in vivo study of its CAR-iNKT cell therapy for advanced gastric cancer, demonstrating complete tumour clearance in a significant number of treated animals. The study showed that five out of seven animals treated with the therapy survived without signs of tumours after a specified period, contrasting with the control group. The findings support the potential of Arovella's technology to address unmet needs in solid tumours and will guide the clinical development strategy for the therapy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries